Pharmacology: affective disorders Flashcards
3 examples of affective disorders?
Depression, mania, bipolar disorder
In affective disorders, there is disrupted interplay between various parts of the brain involved in controlling affect (mood). What are these?
Cortical areas (especially the prefrontal area and the anterior cingulate cortex)
Limbic system (hippocampus and amygdala)
Hypothalamus, pituitary, brainstem
Basal ganglia
Ventral tegmental area and nucleus accumbens
BIOGENIC AMINE HYPOTHESIS
- Is also known as:
- Colloquially, is known as:
- What is the hypothesis? Impacts in depression vs mania?
- Biological mechanisms which may underpin the hypothesis?
- Monoamine hypothesis
- Chemical imbalance
- Affective disorders are due to imbalances of biogenic amines (serotonin and NA) - deficient in depression, surplus in mania
- Receptor abnormality
BIOGENIC AMINE HYPOTHESIS
- Evidence against this hypothesis?
- Not all patients respond to antidepressants
- Drugs quickly affect NT levels, but effectson mood usually take a long time to occur (however, could be due to neuroplasticity taking time to occur).
DEPRESSION
Pathophysiology?
ANTI-DEPRESSANTS
4 synaptic sites of action of antidepressants?
Postsynaptic receptor (increased sensitivty)
Presynaptic receptor (less autoregulation)
Reduced presynaptic breakdown (eg. by MAO in mitochondria)
Reuptake pumps (inhibited)
ANTIDEPRESSANTS
General considerations:
- Up to how long can it take to see their full clinical effect? Why?
- Can adherence be a problem?
- Can suicidal intent be a problem? Why?
- Concerns for using on people under 25?
- 8 weeks - as it can take this long or synaptic changes to occur
- Yes
- Yes: 8 week period; may now have the motivation to carry out plan
- Can impact brain dev, as it’s still growing
7 classes of antidepressants?
- Selective serotonin reputake inhibitors (SSRI’s)
- Selective noradrenaline reuptake inhibitors (NRI’s)
- Serotonin noradrenaline reuptake inhibitors (SNRI’s)
- Tricyclic antidepressants
- Tetracyclic antidepressants
- MAO inhibitors
- Other drugs
ANTIDEPRESSANTS
Selective serotonin reuptake inhibitiors (SSRIs)
- MOA?
- Are they common?
- Are they first line treatment for depression in many cases?
- Can they take time to work, and initially worsen depression?
- Examples?
- Block serotonin reuptake pumps –> more available in synapse
- Yes
- Yes
- Yes
- Sertraline, escitalopram
ANTIDEPRESSANTS
Selective serotonin reuptake inhibitors
- ADRs?
- Insomnia (best taken in the morning)
- Nausea
- Dizziness
- Initial worsening of anxiety and depression, increased suicide risk
- Serotonin syndrome
ANTIDEPRESSANTS
Serotonin syndrome
- What is it?
- What can cause it?
- A syndrome (group of symptoms) associated with too high levels of serotonin
- Some foods and medicines (eg. antidepressants, some opioids/migraine medications) –> high dose of a single drug, taking more than one serotonergic drug, inadequate washout period between drugs
ANTIDEPRESSANTS
Serotonin syndrome
- Is there sufficient evidence supporting the benefits of using 2 or more antidepressants?
- Does this outweigh the risks of serotonin syndrome?
- Why might people be prescribed 2 or more serotonergic drugs?
- No; doesn’t outweigh risk
- May take one for depression, another for another indication (eg. pain/migraine)
ANTIDEPRESSANTS
Serotonin syndrome
- Symptoms? (Don’t memorise them all)
- Hyperreflexia, clonus, tremor, incoordination
- Shivering, sweating, fever
- Diarrhoea
- Mental state challenges - confusion, hypomania, agitation, nervousness
- Severe: tachycardia, hyperthermia, delirium, convulsions, organ system failure, death
ANTIDEPRESSANTS
Selective noradrenaline reuptake inhibitors (NRI’s)
- MOA?
- Are they as common or effective as SSRIs/SNRIs?
- ADRs?
- Example?
Block NA reuptake
No
Dizziness, insomnia
Reboxetine
ANTIDEPRESSANTS
Serotonin noradrenaline reuptake inhibitors (SNRIs)
- MOA?
- Are they newer drugs (compared to SSRI’s and NRI’s?)
- Are they more selective for receptors than the others?
- Block reuptake of both serotonin and noradrenaline
- Yes
- Yes
- Yes